| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |